u/ismael_nwosu

research material is not approved for human use, which is why the clinical record here is thin

Agreed. The denial letter tells you which criterion failed, and answering that specific criterion is the entire job.

Push back: three tests on one lot is one lot. It tells you about that lot and almost nothing about the next one.

Documented eighteen months of what had been tried in a one-page table. That table was the appeal.

Right, and a point or two between services is ordinary. It is agreement, and every month somebody posts it as a scandal.

Cosigning on external review. It is a real mechanism, it is underused, and the deadlines are strict.

Kept every report as a PDF with the batch in the filename. Two years in, it is the most useful folder I own.

Right, and a point or two between services is ordinary. It is agreement, and every month somebody posts it as a scandal.

Careful — the deadline runs from the date on the letter. Waiting for a call back can cost you the appeal entirely.

Cosigning the round-number approach. Reconstituting to something awkward is how you end up drawing 27.5 units at six in the morning.

Cosigning on saying who paid. It is the whole basis on which this log is worth anything.

Started reconstituting everything to a round concentration and the six-in-the-morning error rate went to zero.

That figure is from the obesity programme, and this thread is about the hepatic one.

A denial letter is required to state a reason and to reference the criterion applied. That reference is the handle: request the clinical policy document by its identifier and answer it point by point.

Small fix — external review is independent of the plan. The second-level internal appeal is not.

a template letter that quotes their own criteria back is the strongest one

External review was the thing that finally worked. I did not know it existed until a thread on this board.

Went slowly because everything published describes a deliberate escalation. That is the extent of what I will say about it.

the powder cake sits at the bottom, the volume you add is the volume that counts

three lots beats three tests on one lot

Have you asked for the clinical policy bulletin by number?

external review exists and almost nobody uses it

A series across separate lots estimates a process. Repeat tests on one lot estimate the measurement. Both are useful and they answer different questions.

the diagnosis code on the claim is doing more work than anything you write

What has been documented as tried, and for how long?

Missed a deadline because I counted from when I opened the envelope. That mistake cost me an entire cycle.

units are a volume on a U-100 syringe, not a dose